[Countermeasures for hepatic encephalopathy complicated with liver cirrhosis].
Watanabe
A
A
D000284:Administration, Oral; D000596:Amino Acids / Q000008:administration & dosage / Q000627:therapeutic use; D000641:Ammonia / Q000097:blood; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D006501:Hepatic Encephalopathy / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications*; D010940:Plant Proteins / Q000627:therapeutic use; D012307:Risk Factors; D014888:Wechsler Scales; D015032:Zinc / Q000627:therapeutic use
D000596:Amino Acids; D000900:Anti-Bacterial Agents; D010940:Plant Proteins; D000641:Ammonia; D015032:Zinc